Global

Coronavirus variants may lead to false negative results with molecular tests - FDA

Fri, 2021-01-08 20:24 — mike kraft

Coronavirus variants may lead to false negative results with molecular tests - FDA The U.S. drugs regulator said on Friday genetic variants of COVID-19, including the one found in the UK, could lead to false negative results from some molecular COVID-19 tests, but the risk of the mutations affecting overall testing accuracy is low. Vishwadha Chander U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Coronavirus variants may lead to false negative results with molecular tests - FDA
Log in or register to post comments

Pfizer-BioNTech vaccine not affected by mutation seen in contagious coronavirus variant, study indicates

Fri, 2021-01-08 12:20 — mike kraft

Pfizer vaccine not affected by mutation in contagious coronavirus variant A mutation found in fast-spreading coronavirus variants does not negate the Covid-19 vaccine from Pfizer and BioNTech. Andrew Joseph STAT

A mutation found in fast-spreading coronavirus variants does not negate the Covid-19 vaccine from Pfizer and BioNTech, researchers reported late Thursday.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

People without symptoms spread virus in more than half of cases -- CDC model

Fri, 2021-01-08 10:45 — mike kraft

People without symptoms spread virus in more than half of cases, CDC model finds The finding underscores the importance of following guidelines to wear masks and maintain social distancing. Ben Guarino Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about People without symptoms spread virus in more than half of cases -- CDC model
Log in or register to post comments

240 Israelis found with COVID after vaccination, underscoring need for vigilance

Thu, 2021-01-07 20:28 — mike kraft

240 Israelis found with COVID after vaccination, underscoring need for vigilance Pfizer's shot only begins having an effect 8-10 days after first injection, and only reaches full potential after the second dose timesofisrael

Illustrative: Antibodies attacking SARS-CoV-2 virus (Dr_Microbe;iStock by Getty Images)

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about 240 Israelis found with COVID after vaccination, underscoring need for vigilance
Log in or register to post comments

South Africa, Kenya announce large purchases of COVID-19 Vaccine

Thu, 2021-01-07 19:08 — mike kraft

South Africa buys 1.5 million doses of AstraZeneca vaccine JOHANNESBURG (AP) — South Africa says it will import 1.5 million doses of the AstraZeneca vaccine to inoculate the country's health workers. This is South Africa’s first announcement of the... AP NEWS

JOHANNESBURG (AP) — South Africa says it will import 1.5 million doses of the AstraZeneca vaccine to inoculate the country’s health workers. This is South Africa’s first announcement of the purchase of a COVID-19 vaccine as its cases soar.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about South Africa, Kenya announce large purchases of COVID-19 Vaccine
Log in or register to post comments

Loss of Smell Occurs in 86 Percent of Mild COVID Cases, New Study Finds

Thu, 2021-01-07 18:45 — mike kraft

Loss of Smell Occurs in 86 Percent of Mild COVID Cases, New Study Finds According to researchers, 95 percent of patients who lost their sense of taste or smell recovered it within six months YahooNews

Most patients with mild symptoms of COVID-19 lose their sense of taste and smell but tend to recover it quickly, according to findings from a new study.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Loss of Smell Occurs in 86 Percent of Mild COVID Cases, New Study Finds
Log in or register to post comments

Blood Plasma Reduces Risk of Severe Covid-19 if Given Early

Thu, 2021-01-07 17:22 — mike kraft

A small but rigorous clinical trial in Argentina has found that blood plasma from recovered Covid-19 patients can keep older adults from getting seriously sick with the coronavirus — if they get the therapy within days of the onset of the illness.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Blood Plasma Reduces Risk of Severe Covid-19 if Given Early
Log in or register to post comments

Severe allergic reactions reported in the US after getting COVID-19 vaccine, but CDC says cases are rare

Thu, 2021-01-07 13:13 — mike kraft

Severe allergic reactions reported in the US after getting COVID-19 vaccine, but CDC says cases are rare The CDC detected 21 cases of anaphylaxis in a pool of more than 1.8 million administered first doses, translating to about 11 cases per million doses. Adrianna Rodriguez USA TODAY

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

EU agency authorizes Moderna's COVID-19 vaccine

Wed, 2021-01-06 10:28 — mike kraft

EU agency authorizes Moderna's COVID-19 vaccine AMSTERDAM (AP) — The European Union’s medicines agency gave the green light Wednesday to Moderna Inc.’s COVID-19 vaccine, a decision that gives the 27-nation bloc a second vaccine to use in the... AP NEWS

AMSTERDAM (AP) — The European Union’s medicines agency gave the green light Wednesday to Moderna Inc.’s COVID-19 vaccine, a decision that gives the 27-nation bloc a second vaccine to use in the desperate battle to tame the virus rampaging across the continent.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about EU agency authorizes Moderna's COVID-19 vaccine
Log in or register to post comments

Warning of Shortages, Researchers Look to Stretch Vaccine Supply

Wed, 2021-01-06 10:08 — mike kraft

WASHINGTON — Federal officials and drugmakers, faced with a slower-than-expected rollout of the coronavirus vaccine, are racing to find ways to expand the supply, looking at lowering the required dosage and extracting more doses from the supplies they have.

Just weeks into the vaccine program, scientists at the National Institutes of Health and the drugmaker Moderna are analyzing data to see if they can double the supply of the company’s coronavirus vaccine by cutting doses in half. The study, though long planned, is increasingly urgent in the face of looming shortages as the country tries to fight off a surging pandemic.

Country / Region Tags:

General Topic Tags: